Similar Articles
Long-term cladribine experience in relapsing-remitting multiple sclerosis
Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç
DOI: 10.55697/tnd.2025.293
Issue: 2025, Volume 31 - Issue 3
1266
1051
Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis
Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi
DOI: 10.55697/tnd.2025.323
Issue: 2025, Volume 31 - Issue 4
704
662
Audiovestibular findings according to the subtypes of multiple sclerosis
Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz
DOI: 10.55697/tnd.2025.442
Issue: 2025, Volume 31 - Issue 4
570
727
Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning
Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş
DOI: 10.55697/tnd.2025.511
Issue: 2025, Volume 31 - Issue 4
775
702
Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis
Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci
DOI: 10.55697/tnd.2026.622
Issue: 2026, Volume 32 - Issue 1
0
25